BAFMX
Price
$18.64
Change
+$0.06 (+0.32%)
Updated
Oct 6 closing price
Net Assets
61.02M
RPMGX
Price
$103.40
Change
+$0.24 (+0.23%)
Updated
Oct 6 closing price
Net Assets
26.95B
Interact to see
Advertisement

BAFMX vs RPMGX

Header iconBAFMX vs RPMGX Comparison
Open Charts BAFMX vs RPMGXBanner chart's image
Brown Advisory Mid-Cap Growth Instl
Price$18.64
Change+$0.06 (+0.32%)
VolumeN/A
Net Assets61.02M
T. Rowe Price Mid-Cap Growth
Price$103.40
Change+$0.24 (+0.23%)
VolumeN/A
Net Assets26.95B
BAFMX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
BAFMX vs. RPMGX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFMX is a Hold and RPMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 27B vs. BAFMX (61M). BAFMX (0.00) and RPMGX (0.00) have matching dividends . BAFMX was incepted earlier than RPMGX: BAFMX (7 years) vs RPMGX (33 years). BAFMX (0.85) is less costly to investors than RPMGX (0.75). BAFMX is a more actively managed with annual turnover of: 63.00 vs. RPMGX (22.60). RPMGX has a lower initial minimum investment than BAFMX: RPMGX (2500) vs BAFMX (1000000). BAFMX annual gain was more profitable for investors over the last year : 14.13 vs. RPMGX (-5.37). BAFMX return over 5 years is better than : 17.59 vs. RPMGX (-1.72).
BAFMXRPMGXBAFMX / RPMGX
Total Expense Ratio0.830.75111%
Annual Report Gross Expense Ratio0.850.75113%
Fund Existence7 years33 years-
Gain YTD10.0063.439291%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets61M27B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.13-5.37-263%
Returns for 3 years50.9320.28251%
Returns for 5 years17.59-1.72-1,022%
Returns for 10 yearsN/A29.95-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NROM0.18N/A
+2.25%
Noble Roman's, Inc.
APCFF0.06N/A
N/A
ATLAS PEARLS LTD
NZRFF1.49N/A
N/A
CHANNEL INFRASTRUCTURE NZ LTD
SRTOY22.99N/A
N/A
Sartorius Stedim Biotech
EDVGF2.68N/A
N/A
ENDEAVOUR GROUP LTD.